VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 52 filers reported holding VOR BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,432 | -49.9% | 17,996 | -28.2% | 0.00% | -50.0% |
| Q2 2023 | $74,694 | -40.5% | 25,065 | -8.4% | 0.00% | -42.9% |
| Q1 2023 | $125,541 | +99.8% | 27,351 | +150.7% | 0.01% | +75.0% |
| Q4 2022 | $62,847 | -4.8% | 10,911 | -25.0% | 0.00% | -20.0% |
| Q3 2022 | $66,000 | +11.9% | 14,549 | +12.9% | 0.01% | +25.0% |
| Q2 2022 | $59,000 | +9.3% | 12,890 | +0.2% | 0.00% | 0.0% |
| Q1 2022 | $54,000 | -55.4% | 12,864 | -12.3% | 0.00% | -55.6% |
| Q4 2021 | $121,000 | -61.7% | 14,676 | -22.2% | 0.01% | -59.1% |
| Q3 2021 | $316,000 | -60.3% | 18,868 | -69.4% | 0.02% | -26.7% |
| Q2 2021 | $796,000 | – | 61,572 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $73,923,000 | 13.88% |
| RA Capital Management | 11,120,973 | $129,226,000 | 2.28% |
| Paradigm Biocapital Advisors LP | 629,342 | $7,313,000 | 2.09% |
| OUP Management Co., LLC | 374,714 | $4,354,000 | 1.96% |
| JOHNSON & JOHNSON | 1,074,658 | $12,488,000 | 1.42% |
| Sarissa Capital Management LP | 707,010 | $8,215,000 | 0.71% |
| Woodline Partners LP | 1,111,123 | $12,911,000 | 0.18% |
| Artal Group S.A. | 550,000 | $6,391,000 | 0.17% |
| Orbimed Advisors | 833,333 | $9,683,000 | 0.12% |
| Laurion Capital Management LP | 857,308 | $9,962,000 | 0.10% |